SYMBICORT is NOT a rescue medication and does NOT replace fast-acting inhalers to treat acute symptoms.
Mean percent change from baseline FEV1 was measured at day of randomization, weeks 2 and 123.
Majority of FEV1 improvement at 15 minutes each time† in patients taking SYMBICORT 160/4.5 (n=124)3
Significant lung function improvement with continuous control, as demonstrated in a 12-week study1,3
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.